Anula Jayasuriya - Jul 1, 2023 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role
Director
Signature
/s/ Jonathan Wolin, Attorney-in-Fact
Stock symbol
JAGX
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
4
Date filed
8/14/2023, 04:55 PM
Previous filing
Apr 6, 2023
Next filing
Jan 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAGX Common Stock Award $0 +1.72K $0.00 1.72K Jul 1, 2023 Direct
transaction JAGX Common Stock Award $0 +68.6K +3991.15% $0.00 70.3K Aug 14, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAGX Restricted stock units Award $0 -1.72K -100% $0.00* 0 Jul 1, 2023 Common Stock 1.72K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the issuer's 2014 Stock Incentive Plan (the "Plan").
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock.
F3 The RSUs vested in full on July 1, 2023, the first anniversary of the service start date. Vested shares were delivered to the reporting person on the vesting date provided in the grant notice, subject to the reporting person's continuous services through such vesting date.